Skip to Main Content

Paper Details

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis.
RMD Open
49
2023
Author NameAffiliation
Hannah L Palac
Emma Guttman-YasskyIcahn School of Medicine at Mount Sinai
  • 1 - 2

Datasets

Release 1.2